Valuation: RAMM Pharma Corp.

Market Cap 1.19M 850K 742K 698K 637K 81.52M 1.2M 8.37M 3.22M 41.54M 3.2M 3.13M 134M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 335K 292K 275K 251K 32.12M 471K 3.3M 1.27M 16.37M 1.26M 1.23M 52.74M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 08/12/2022
Director TitleAgeSince
Director/Board Member - 30/09/2019
Director/Board Member 82 30/09/2019
Director/Board Member 66 30/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 852K
+1.04%+4.41%+54.91%+104.50% 1,028B
-0.19%+1.46%+52.94%+65.41% 651B
+0.20%+2.86%+18.88%+72.18% 466B
+2.24%+5.98%+37.61%+42.44% 346B
+0.90%+3.66%+18.79%+25.03% 266B
+0.48%+7.28%+11.11%+14.70% 259B
+1.95%+4.19%+37.75%+44.83% 208B
-7.65%-5.95%-33.09%-60.76% 191B
+0.30%+4.76%+31.97%+98.58% 186B
Average -7.77%+3.26%+25.65%+45.21% 400.19B
Weighted average by Cap. +0.11%+3.09%+35.56%+62.43%

Financials

2024 2025
Net sales 4.34M 3.09M 2.7M 2.54M 2.31M 296M 4.35M 30.43M 11.71M 151M 11.63M 11.37M 487M 3.36M 2.39M 2.09M 1.97M 1.79M 229M 3.36M 23.56M 9.06M 117M 9M 8.8M 377M
Net income -16.5M -11.75M -10.26M -9.65M -8.8M -1.13B -16.52M -116M -44.49M -574M -44.19M -43.2M -1.85B -8.91M -6.34M -5.54M -5.21M -4.75M -608M -8.92M -62.45M -24.02M -310M -23.86M -23.32M -999M
Net Debt -626K -446K -389K -366K -334K -42.73M -626K -4.39M -1.69M -21.77M -1.68M -1.64M -70.16M -723K -515K -450K -423K -386K -49.4M -724K -5.07M -1.95M -25.17M -1.94M -1.89M -81.12M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!